Universe Pharmaceuticals INC (UPC)
USD 3.57
(-2.46%)
USD 3.57
(-2.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 10.07 Million USD | -52.88% |
| 2022 | 21.89 Million USD | -13.56% |
| 2021 | 25.32 Million USD | 79.7% |
| 2020 | 14.09 Million USD | 5.12% |
| 2019 | 13.4 Million USD | -0.01% |
| 2018 | 13.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.24 Million USD | 0.0% |
| 2023 Q4 | 4.06 Million USD | 0.0% |
| 2023 FY | 10.31 Million USD | -52.88% |
| 2023 Q2 | 6.01 Million USD | 0.0% |
| 2022 Q4 | 8.05 Million USD | 0.0% |
| 2022 FY | 21.89 Million USD | -13.56% |
| 2022 Q2 | 13.63 Million USD | 0.0% |
| 2021 FY | 25.32 Million USD | 79.7% |
| 2021 Q2 | 11.87 Million USD | 0.0% |
| 2021 Q4 | 13.26 Million USD | 0.0% |
| 2020 Q4 | 3.52 Million USD | 0.0% |
| 2020 FY | 14.09 Million USD | 5.12% |
| 2020 Q3 | 3.52 Million USD | 0.0% |
| 2020 Q2 | 3.52 Million USD | 0.0% |
| 2020 Q1 | 3.52 Million USD | 5.12% |
| 2019 Q2 | 3.35 Million USD | 0.0% |
| 2019 FY | 13.4 Million USD | -0.01% |
| 2019 Q4 | 3.35 Million USD | 0.0% |
| 2019 Q3 | 3.35 Million USD | -0.0% |
| 2018 Q3 | 3.35 Million USD | -0.0% |
| 2018 Q4 | 3.35 Million USD | 0.0% |
| 2018 Q2 | 3.35 Million USD | 0.0% |
| 2018 FY | 13.4 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 96.91% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -1719.207% |
| Embecta Corp. | 749.9 Million USD | 98.656% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 97.945% |
| PainReform Ltd. | -15 Thousand USD | 67285.867% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -20.85% |
| SCYNEXIS, Inc. | 124.51 Million USD | 91.906% |
| Journey Medical Corporation | 52.52 Million USD | 80.812% |
| Safety Shot Inc | -74.45 Thousand USD | 13635.168% |
| Alpha Teknova, Inc. | 10.29 Million USD | 2.118% |
| Bright Green Corporation | -237.01 Thousand USD | 4351.983% |
| Procaps Group, S.A. | 239.56 Million USD | 95.793% |
| Alvotech | -69.42 Million USD | 114.517% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 96.699% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 66.127% |
| Cosmos Health Inc. | 4.34 Million USD | -131.698% |
| Dynavax Technologies Corporation | 182.11 Million USD | 94.466% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 86.207% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 97.66% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -20.85% |
| Theratechnologies Inc. | 62.12 Million USD | 83.779% |
| Harrow Health, Inc. | 90.55 Million USD | 88.871% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -112.389% |
| Biofrontera Inc. | 16.62 Million USD | 39.388% |
| DURECT Corporation | 6.83 Million USD | -47.532% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 98.076% |
| Cronos Group Inc. | 6.99 Million USD | -44.157% |
| OptiNose, Inc. | 62.35 Million USD | 83.838% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 97.716% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 3426.033% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -229.971% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 96.747% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -86.817% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 69.904% |
| Radius Health, Inc. | 307.71 Million USD | 96.725% |
| ProPhase Labs, Inc. | 16.23 Million USD | 37.94% |
| Phibro Animal Health Corporation | 312.48 Million USD | 96.775% |
| Procaps Group S.A. | 239.56 Million USD | 95.793% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -674.031% |
| Viatris Inc. | 6.43 Billion USD | 99.843% |
| Rockwell Medical, Inc. | 8.7 Million USD | -15.784% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 81.538% |
| SIGA Technologies, Inc. | 122.09 Million USD | 91.746% |
| Tilray Brands, Inc. | 223.35 Million USD | 95.488% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 75.919% |
| Shineco, Inc. | 882.16 Thousand USD | -1042.399% |
| PetIQ, Inc. | 252.74 Million USD | 96.013% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 1451.669% |
| Incannex Healthcare Limited | 12 Thousand USD | -83882.333% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.454% |
| Alimera Sciences, Inc. | 61.17 Million USD | 83.525% |
| Silver Spike Investment Corp. | 8.1 Million USD | -24.378% |
| Assertio Holdings, Inc. | 125.04 Million USD | 91.941% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 148064.763% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -140.455% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -53.72% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 518.139% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 62.836% |
| Hempacco Co., Inc. | -1.21 Million USD | 928.887% |
| Talphera, Inc. | -4.89 Million USD | 305.881% |
| Alvotech | -69.42 Million USD | 114.517% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 95.454% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 98.58% |
| Currenc Group, Inc. | 17.35 Million USD | 41.935% |
| Kamada Ltd. | 52.59 Million USD | 80.838% |
| Indivior PLC | 907 Million USD | 98.889% |
| Evoke Pharma, Inc. | 4.97 Million USD | -102.418% |
| Flora Growth Corp. | 17.73 Million USD | 43.185% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 518.139% |
| Evolus, Inc. | 140.52 Million USD | 92.828% |
| HUTCHMED (China) Limited | 453.55 Million USD | 97.778% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 97.07% |
| Akanda Corp. | 111.44 Thousand USD | -8942.593% |